Shareholder Class Actions

Shareholders say 3Com is selling itself too cheaply to Hewlett-Packard, for $2.7 billion or $7.90 a share, in Delaware Chancery Court.

Hemispherx Biopharma inflated its share price by failing to report on FDA decisions and delays for its new drugs, including Ampligen, shareholders claim in Philadelphia Federal Court.

The former CEO of The Jolt Co. claims Emigrant Capital Corp. hurt him and common shareholders when it took over the company and squeezed him out, in Monroe County Court, N.Y.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Email *

Submit